Skip navigation

Develop and Implement Procedures that Survive the Lifecycle

December 4-6, 2017
  • Philadelphia, PA

Debora Aguiar
Director, Quality Control Technical Services
Genzyme

Karen Ginsbury, BPharm, MSc
Founder and CEO
PCI Pharma Ltd.

David Kesselring, PhD
Principal Analytical Chemist
Mallinckrodt Pharmaceuticals

Jerry Lanese, PhD
President
The Lanese Group, LLC

Ty Mew
President
Ofni Systems

Lina Patel, PhD
Director, Quality Operations Bio-Analytical Laboratory
Merck Manufacturing Division

Ronald D. Snee, PhD
President
Snee Associates LLC

Perceval Sondag
Senior Manager, Statistics
PharmaLex Development Services

Jason Starkey, PhD
Senior Director, Analytical Research and Development,
BioTherapeutics Pharmaceutical Sciences
Pfizer Inc

Andy Wang, PhD
Principal Scientist, Analytical Development
Janssen Pharm, Johnson & Johnson

Jane Weitzel, BSc Honors
Independent Consultant

Chris Wubbolt, BS
Principal Consultant
QACV Consulting, LLC

Kangping Xiao, PhD
Director, Global Innovation and
Development Center – Analytical Development
Bayer Consumer Health

Debora Aguiar
Director, Quality Control Technical Services
Genzyme

Karen Ginsbury, BPharm, MSc
Founder and CEO
PCI Pharma Ltd.

David Kesselring, PhD
Principal Analytical Chemist
Mallinckrodt Pharmaceuticals

Jerry Lanese, PhD
President
The Lanese Group, LLC

Ty Mew
President
Ofni Systems

Lina Patel, PhD
Director, Quality Operations Bio-Analytical Laboratory
Merck Manufacturing Division

Ronald D. Snee, PhD
President
Snee Associates LLC

Perceval Sondag
Senior Manager, Statistics
PharmaLex Development Services

Jason Starkey, PhD
Senior Director, Analytical Research and Development,
BioTherapeutics Pharmaceutical Sciences
Pfizer Inc

Andy Wang, PhD
Principal Scientist, Analytical Development
Janssen Pharm, Johnson & Johnson

Jane Weitzel, BSc Honors
Independent Consultant

Chris Wubbolt, BS
Principal Consultant
QACV Consulting, LLC

Kangping Xiao, PhD
Director, Global Innovation and
Development Center – Analytical Development
Bayer Consumer Health